Notes from the Field: A Cluster of Multi-Strain Invasive Pneumococcal Disease Among Persons Experiencing Homelessness and Use of Pneumococcal Conjugate Vaccine - El Paso County, Colorado, 2022
This report describes cases of invasive pneumococcal disease among people experiencing homelessness in Colorado. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - November 16, 2023 Category: American Health Tags: MMWR Morbidity & Mortality Weekly Report Source Type: news
Provider Knowledge of Pneumococcal Vaccine Recommendations Provider Knowledge of Pneumococcal Vaccine Recommendations
Pneumococcal vaccine coverage remains low. This survey found that many health care providers are confused about the nuances surrounding recommendations for pneumococcal vaccine for adult patients.Morbidity & Mortality Weekly Report (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - November 15, 2023 Category: Allergy & Immunology Tags: Public Health & Prevention Journal Article Source Type: news
Penbraya Vaccine for Meningitis Vaccine May Be On the Way
THURSDAY, Oct. 26, 2023 -- A new vaccine recommended Wednesday by independent advisers to the U.S. Centers for Disease Control and Prevention could provide more comprehensive protection from meningitis. The CDC is weighing the advisers ' ... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 26, 2023 Category: Pharmaceuticals Source Type: news
CDC Panel Backs Broader Use of Mpox Vaccine
(MedPage Today) -- The CDC's vaccine advisors on Wednesday endorsed the use of the mpox vaccine for high-risk adults even after the outbreak, along with a newly approved pentavalent meningococcal vaccine for adolescents and younger adults.
Broader... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - October 26, 2023 Category: Infectious Diseases Source Type: news
Improved Meningitis Vaccine, Penbraya, May Be On the Way
THURSDAY, Oct. 26, 2023 -- A new vaccine recommended Wednesday by independent advisers to the U.S. Centers for Disease Control and Prevention could provide more comprehensive protection from meningitis.
The shot would protect against five types of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 26, 2023 Category: General Medicine Source Type: news
First malaria vaccine slashes early childhood deaths
In a major analysis in Africa, the first vaccine approved to fight malaria cut deaths among young children by 13% over nearly 4 years, the World Health Organization (WHO) reported last week. The huge evaluation of a pilot rollout of the vaccine, called RTS,S or Mosquirix and made by GlaxoSmithKline, also showed a 22% reduction in severe malaria in kids young enough to receive a three-shot series. Hundreds of thousands of children are born annually in the parts of Ghana, Kenya, and Malawi included in the analysis, for which WHO revealed the final data on 20 October at the annual meeting of the American Society of Tropical M...
Source: ScienceNOW - October 24, 2023 Category: Science Source Type: news
FDA Approves Pfizer ’s Vaccine for Meningococcal Disease
The U.S. Food and Drug Administration has approved Pfizer’s application for Penbraya, a vaccine for people 10 through 25 that will offer protection against the five main kinds of bacteria that cause meningitis and blood poisoning. (Source: WebMD Health)
Source: WebMD Health - October 23, 2023 Category: Consumer Health News Source Type: news
New Meningococcal Vaccine Wins FDA Approval New Meningococcal Vaccine Wins FDA Approval
The single shot will cover the five most common serogroups that cause meningococcal disease in children and young adults.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - October 23, 2023 Category: Infectious Diseases Tags: Infectious Diseases News Alert Source Type: news
FDA approves PENBRAYA ™, the first and only vaccine for the prevention of the five most common serogroups causing meningococcal disease in adolescents
Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration (FDA) has approved PENBRAYA™ (meningococcal groups A, B, C, W and Y vaccine), the first and only pentavalent vaccine that provides coverage against the most common serogroups causing meningococcal disease in adolescents and young adults 10 through 25 years of age. (Source: World Pharma News)
Source: World Pharma News - October 23, 2023 Category: Pharmaceuticals Tags: Featured Pfizer Business and Industry Source Type: news
FDA Approves Penbraya (meningococcal groups A, B, C, W and Y vaccine) for the Prevention of the Five Most Common Serogroups Causing Meningococcal Disease in Adolescents
NEW YORK--(BUSINESS WIRE) October 20, 2023 -- Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved Penbraya™ (meningococcal groups A, B, C, W and Y vaccine), the first and only pentavalent... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - October 20, 2023 Category: Drugs & Pharmacology Source Type: news
How seniors can access 4 key vaccines this fall — for COVID, flu, pneumonia, and RSV
COVID-19, influenza, pneumococcal, and — for the first time — respiratory syncytial virus (RSV) vaccines will all be available this fall for older adults. But medical experts warn high costs and patchwork rollouts could be barriers for seniors trying to protect themselves. (Source: CBC | Health)
Source: CBC | Health - October 7, 2023 Category: Consumer Health News Tags: News/Health Source Type: news
ACIP Updates: Recommendations for Use of 20-Valent Pneumococcal Conjugate Vaccine in Children - United States, 2023
This report describes an ACIP update recommending the use of the 20-valent pneumococcal conjugate vaccine in children. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - September 28, 2023 Category: American Health Tags: MMWR Morbidity & Mortality Weekly Report Source Type: news
Pneumococcal Infection Reduced in Children With Sickle Cell Since PCV13
TUESDAY, Sept. 19, 2023 -- For children with sickle cell disease (SCD), the rates of invasive pneumococcal infection (IPD) have decreased since introduction of pneumococcal conjugate vaccines (PCVs), according to a study published online Sept. 12 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 19, 2023 Category: Pharmaceuticals Source Type: news
Providers Have Inadequate Awareness of PCV20 Vaccination Recommendations
FRIDAY, Sept. 8, 2023 -- Two-thirds of health care providers agree or strongly agree with expanding recommendations for the new 20-valent pneumococcal conjugate vaccine (PCV20), according to research published in the Sept. 8 issue of the U.S.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 8, 2023 Category: Pharmaceuticals Source Type: news
Health Care Provider Knowledge and Attitudes Regarding Adult Pneumococcal Conjugate Vaccine Recommendations - United States, September 28-October 10, 2022
This report describes knowledge gaps and implementation challenges among health care providers in meeting pneumococcal vaccine recommendations. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - September 7, 2023 Category: American Health Tags: MMWR Morbidity & Mortality Weekly Report Source Type: news
